A study of more than one million adolescents reveals a marked association between a low BMI in adolescence and an increased risk of osteoporosis in adulthood.
Obesity Canada experts provide 13 new and updated recommendations on the effectiveness, safety and appropriate use of pharmacotherapy in the management of obesity in adults.
A new report says the prevalence of obesity increased faster during the COVID-19 pandemic than it did over the course of more than a decade beforehand, specifically in young adults.
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.
To coincide with the release on Canada’s new guidelines for obesity in children, Obesity Canada is offering a new free introductory course on pediatric obesity care.
